FFI Holdings Limited (FFI.AX)
AUD 3.75
(0.0%)
AUD 3.75
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.21 Million | 3.77 Million | -989.32 Thousand | 2.9 Million | 2.3 Million | 2.69 Million |
| Net Income | 1.73 Million | 1.74 Million | 1.21 Million | 8.72 Million | 3.43 Million | 3.29 Million |
| Depreciation & Amortization | 931.43 Thousand | 930.92 Thousand | 853.82 Thousand | 798.94 Thousand | 727.47 Thousand | 791.84 Thousand |
| Deferred income taxes | - | - | - | 1.23 Million | 48.96 Thousand | -514.38 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.57 Million | 1.09 Million | -3.07 Million | -1.87 Million | -1.8 Million | -1.66 Million |
| Other non-cash items | 2.11 Million | 1.09 Million | 9910.00 | -2.91 Million | 2.39 Million | -1.39 Million |
| Investing Cash Flow | -7.48 Million | -1.87 Million | -1.21 Million | 3.03 Million | 4.72 Million | -1.84 Million |
| Investments in PPE | -7.31 Million | -1.13 Million | -1.18 Million | -1.32 Million | -1.92 Million | -1.24 Million |
| Acquisitions | - | - | 36 Thousand | - | 1.26 Million | 3523.00 |
| Investment purchases | -5.52 Million | -746.42 Thousand | -64.62 Thousand | -147.35 Thousand | -239.52 Thousand | -600.22 Thousand |
| Sales/Maturities of investments | - | - | -32.89 Thousand | - | 170 Thousand | 596.7 Thousand |
| Other Investing Activities | -246.92 Thousand | -449.02 Thousand | 32.89 Thousand | 4.5 Million | 5.45 Million | -596.7 Thousand |
| Financing Cash Flow | 2.93 Million | 82 Thousand | -2.55 Million | -2.65 Million | -6.94 Million | -2.11 Million |
| Debt repayment | -4 Million | -82 Thousand | -22.14 Thousand | -24.29 Thousand | -4.5 Million | -30.62 Thousand |
| Dividends payments | -1.07 Million | - | -2.58 Million | -2.69 Million | -2.47 Million | -2.14 Million |
| Common Stock Repurchased | - | - | -34.64 Thousand | -24.29 Thousand | - | - |
| Common Stock Issuance | - | - | 12.5 Thousand | 12.5 Thousand | - | - |
| Other Financing Activities | 11.66 Thousand | 2.75 Million | 76.44 Thousand | 72.87 Thousand | 25.1 Thousand | 61.25 Thousand |
| Accounts receivables | -900.69 Thousand | -640.06 Thousand | -1.22 Million | 442 Thousand | 32.48 Thousand | -880.4 Thousand |
| Accounts payables | -321.05 Thousand | -1.72 Million | 3.41 Million | -1.36 Million | 1.05 Million | 449.88 Thousand |
| Inventory | -1.04 Million | 3.13 Million | -4.59 Million | -541.75 Thousand | -2.13 Million | -783.93 Thousand |
| Other working capital | -631.16 Thousand | 334.27 Thousand | -664.86 Thousand | -411.53 Thousand | -760.07 Thousand | -449.88 Thousand |
| Cash at beginning of period | 2.68 Million | 705.71 Thousand | 5.46 Million | 2.18 Million | 2.1 Million | 3.36 Million |
| Cash at end of period | 359.87 Thousand | 2.68 Million | 705.71 Thousand | 5.46 Million | 2.18 Million | 2.1 Million |
| Capital Expenditure | -7.31 Million | -1.13 Million | -1.18 Million | -1.32 Million | -1.92 Million | -1.24 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.32 Million | 1.98 Million | -4.75 Million | 3.28 Million | 81.63 Thousand | -1.26 Million |
| Free Cash Flow | -5.1 Million | 2.64 Million | -2.17 Million | 1.57 Million | 377.98 Thousand | 1.44 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.73 Million | 39.26 Thousand | 1.69 Million | 1.74 Million | 1.27 Million | 469.23 Thousand |
| Depreciation & Amortization | 931.43 Thousand | 463.23 Thousand | 468.19 Thousand | 930.92 Thousand | 448.26 Thousand | 482.66 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -454.32 Thousand | -2.57 Million | - | 1.09 Million | 2.2 Million | - |
| Other non-cash items | 4.12 Million | 2.06 Million | 987.33 Thousand | 1.09 Million | 1.4 Million | 1.55 Million |
| Investing Cash Flow | -7.48 Million | -6.58 Million | -897.13 Thousand | -1.87 Million | -1.31 Million | -566.53 Thousand |
| Investments in PPE | -1.95 Million | -6.57 Million | -822.48 Thousand | -1.13 Million | -565.67 Thousand | -566.53 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -5.52 Million | -5.45 Million | -74.65 Thousand | -746.42 Thousand | -746.42 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -7675.00 | -74.65 Thousand | -449.02 Thousand | -449.02 Thousand | - |
| Financing Cash Flow | 2.93 Million | 3.99 Million | -1.06 Million | 82 Thousand | 82 Thousand | - |
| Debt repayment | -4.01 Million | -4.01 Million | -11.66 Thousand | -82 Thousand | - | - |
| Dividends payments | -1.07 Million | - | -1.07 Million | - | - | - |
| Common Stock Repurchased | - | -1.00 | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 6142.00 | 3.99 Million | 17.81 Thousand | 2.75 Million | 82 Thousand | - |
| Accounts receivables | -900.69 Thousand | -900.69 Thousand | - | -640.06 Thousand | -640.06 Thousand | - |
| Accounts payables | -321.05 Thousand | - | - | -1.72 Million | - | - |
| Inventory | -1.04 Million | -1.04 Million | - | 3.13 Million | 3.13 Million | - |
| Other working capital | 1.8 Million | -631.16 Thousand | - | 334.27 Thousand | -281.73 Thousand | - |
| Cash at beginning of period | 2.68 Million | 2.94 Million | 2.68 Million | 705.71 Thousand | 1.67 Million | 705.71 Thousand |
| Cash at end of period | 359.87 Thousand | 359.87 Thousand | 2.94 Million | 2.68 Million | 2.68 Million | 1.67 Million |
| Capital Expenditure | -1.95 Million | -6.57 Million | -822.48 Thousand | -1.13 Million | -565.67 Thousand | -566.53 Thousand |
| Effect of forex changes on cash | - | - | 2.68 Million | - | -2.68 Million | - |
| Net cash flow / Change in cash | -2.32 Million | -2.58 Million | 260.26 Thousand | 1.98 Million | 1 Million | 972.48 Thousand |
| Free Cash Flow | 260.96 Thousand | -6.57 Million | 1.39 Million | 2.64 Million | 1.67 Million | 972.48 Thousand |
URAL
CLGPF
603936
SVCBF
CRP
HTCTF